Hengda Zeng

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Corrigendum to "HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1" [Redox Biology 77 (2024) 103392].

Corrigendum to "HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1" [Redox Biology 77 (2024) 103392].

Journal: Redox biology

Published: April 09, 2026

Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study.

Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study.

Journal: OncoTargets and therapy

Published: May 02, 2025

Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer.

Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: March 05, 2025

Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer.

Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer.

Journal: International journal of biological macromolecules

Published: September 10, 2024

HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1.

HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1.

Journal: Redox biology

Published: July 02, 2024

Comparative efficacy of commercial oral poly-herbal traditional Chinese medicine formulations combined with western medicine in benign prostatic hyperplasia management: a systematic review and network meta-analysis.

Comparative efficacy of commercial oral poly-herbal traditional Chinese medicine formulations combined with western medicine in benign prostatic hyperplasia management: a systematic review and network meta-analysis.

Journal: Frontiers in pharmacology

Published: December 19, 2023

Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.

Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.

Journal: Journal of translational medicine

Published: August 11, 2023

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.

Journal: Frontiers in immunology

Published: December 13, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026